Ingevity Corporation cash flow to debt ratio of 26.65% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Ingevity Corporation's free cash flow has increased 436.27% from $51.00M last year to $273.50M, signaling increasing performance

Ingevity Corporation's debt to equity ratio is 26.36, which means that the company's assets are unhealthy financed, signaling financial risk.

Ingevity Corporation's debt has increased relative to shareholder equity from 7.45 last year to 26.36 today, signaling weakened financials

Ingevity Corporation has a net debt to EBITDA ratio of 31.14x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Ingevity Corporation's interest coverage ratio of 3.73 indicates that earnings with good margin can cover interest payments on company debt

Ingevity Corporation's profit margin has increased (-115.21%) in the last year from -30.60% to 4.65%, signaling increasing performance

Ingevity Corporation's short-term assets of $454.20M exceed its short-term liabilities of $341.30M

Ingevity Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Ingevity Corporation's return on equity of 85.17%, is higher than 15.00%, indicating good performance

Ingevity Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Ingevity Corporation had positive net income in only 2 out of 5 years, indicating unstable earnings

Ingevity Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Ingevity Corporation has a free cash flow yield of 10.33%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Ingevity Corporation's yearly earnings has increased -61.17% since last year from $-430.30M to $-167.10M, signaling increasing performance

Ingevity Corporation's yearly revenue has decreased 16.98% since last year from $1.41B to $1.17B, signaling decreasing performance

ROIC 12.32% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Ingevity Corporation's 3-year revenue CAGR of -11.21% is negative, indicating declining revenue over the past 3 years

Ingevity Corporation had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Ingevity Corporation had positive ROE in only 2 out of 5 years, indicating inconsistent returns on equity

Ingevity Corporation is overvalued relative to its fair value price of 66.24 based on Discounted Cash Flow model

Ingevity Corporation has an earnings yield of 2.00%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Ingevity Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Ingevity Corporation has an EV/EBITDA ratio of 101.95x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Ingevity Corporation is overvalued relative to its fair value price of 54.28 based on Earnings Fair Value model

Ingevity Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Ingevity Corporation has a price-to-book ratio of 57.49x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Ingevity Corporation has a price-to-sales ratio of 2.32x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue